Tenaya Therapeutics (TNYA) Assets (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Assets of $135.1 million for Q1 2026, down 6.17% year-over-year from $144.0 million in Q1 2025, and down 8.07% quarter-over-quarter from $146.9 million in Q4 2025.
Tenaya Therapeutics (TNYA) Assets (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Assets history runs 7 years deep, the most recent figure standing at $135.1 million for Q1 2026.
- In Q1 2026, Assets fell 6.17% year-over-year to $135.1 million; the TTM figure through Mar 2026 stood at $135.1 million (down 6.17% YoY), while the FY2025 annual figure was $146.9 million, up 22.5% from the prior year.
- Assets for Q1 2026 stood at $135.1 million, down from $146.9 million in the prior quarter.
- The five-year high for Assets was $281.5 million in Q1 2022, with the low at $105.0 million in Q3 2025.
- The 5-year median for Assets is $170.5 million (2023), against an average of $184.4 million.
- The sharpest annual moves came in 2022 and 2023: Assets jumped 63.12% in 2022, then tumbled 38.87% in 2023.
- Tenaya Therapeutics' Assets stood at $278.9 million in 2022, then plunged by 38.87% to $170.5 million in 2023, then retreated by 29.66% to $119.9 million in 2024, then increased by 22.5% to $146.9 million in 2025, then fell by 8.07% to $135.1 million in 2026.
- Business Quant data shows TNYA's Assets at $135.1 million in Q1 2026, $146.9 million in Q4 2025, and $105.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | 19.82 Bn |
| 10 | Tenaya Therapeutics | 155.15 Mn | 155.15 Mn | - | 93.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.54 Mn |
| Mar 31, 2026 | 135.07 Mn |
| Dec 31, 2025 | 146.92 Mn |
| Sep 30, 2025 | 104.98 Mn |
| Jun 30, 2025 | 122.15 Mn |
| Mar 31, 2025 | 143.95 Mn |
| Dec 31, 2024 | 119.94 Mn |
| Sep 30, 2024 | 140.58 Mn |
| Jun 30, 2024 | 163.19 Mn |
| Mar 31, 2024 | 184.90 Mn |
| Dec 31, 2023 | 170.52 Mn |
| Sep 30, 2023 | 193.40 Mn |
| Jun 30, 2023 | 220.75 Mn |
| Mar 31, 2023 | 245.34 Mn |
| Dec 31, 2022 | 278.95 Mn |
| Sep 30, 2022 | 226.31 Mn |
| Jun 30, 2022 | 255.93 Mn |
| Mar 31, 2022 | 281.50 Mn |
| Dec 31, 2021 | 314.19 Mn |
| Sep 30, 2021 | 331.79 Mn |